193 related articles for article (PubMed ID: 1323988)
1. Retinoic acid and its rearranged receptor in the etiology and treatment of acute promyelocytic leukemia.
Frankel SR; Miller WH; Dmitrovsky E
Oncology (Williston Park); 1992 Aug; 6(8):74-78, 83; discussion 84, 87-8. PubMed ID: 1323988
[TBL] [Abstract][Full Text] [Related]
2. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
Degos L
Int J Cell Cloning; 1992 Mar; 10(2):63-9. PubMed ID: 1312109
[TBL] [Abstract][Full Text] [Related]
3. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
Chen Z; Chen SJ; Wang ZY
C R Acad Sci III; 1994 Dec; 317(12):1135-41. PubMed ID: 7697468
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
Cornic M; Guidez F; Delva L; Agadir A; Degos L; Chomienne C
Bull Cancer; 1992; 79(7):697-704. PubMed ID: 1334741
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid and its rearranged receptor in the treatment of acute promyelocytic leukemia.
Miller WH; Dmitrovsky E
Important Adv Oncol; 1993; ():81-90. PubMed ID: 8389321
[TBL] [Abstract][Full Text] [Related]
7. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus.
de Thé H; Chomienne C; Lanotte M; Degos L; Dejean A
Nature; 1990 Oct; 347(6293):558-61. PubMed ID: 2170850
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid in acute promyelocytic leukemia: the promise and the paradox.
Clarkson B
Cancer Cells; 1991 Jun; 3(6):211-20. PubMed ID: 1911035
[TBL] [Abstract][Full Text] [Related]
9. [Acute promyelocytic leukemia. The therapeutic advances].
de Lacerda JF; do Carmo JA; de Lacerda JM
Acta Med Port; 1993 Oct; 6(10):473-80. PubMed ID: 8285119
[TBL] [Abstract][Full Text] [Related]
10. Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
Guidez F; Huang W; Tong JH; Dubois C; Balitrand N; Waxman S; Michaux JL; Martiat P; Degos L; Chen Z
Leukemia; 1994 Feb; 8(2):312-7. PubMed ID: 8309256
[TBL] [Abstract][Full Text] [Related]
11. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
Tallman MS
Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of distinct PML-RAR-alpha fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction.
Chen SJ; Chen Z; Chen A; Tong JH; Dong S; Wang ZY; Waxman S; Zelent A
Oncogene; 1992 Jun; 7(6):1223-32. PubMed ID: 1375719
[TBL] [Abstract][Full Text] [Related]
13. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
[TBL] [Abstract][Full Text] [Related]
14. Acute promyelocytic leukemia (AML-M3)--Part 2: Molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy.
Randolph TR
Clin Lab Sci; 2000; 13(2):106-16. PubMed ID: 11066449
[TBL] [Abstract][Full Text] [Related]
15. [Molecular study on the distinct isoforms of PML-RAR alpha fusion gene transcripts in acute promyelocytic leukemia].
Geng JP
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):197-200, 252. PubMed ID: 8395310
[TBL] [Abstract][Full Text] [Related]
16. [Retinoids and acute promyelocytic leukemia].
Hashimoto Y; Shudo K
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2203-9. PubMed ID: 1656889
[TBL] [Abstract][Full Text] [Related]
17. Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties.
Pandolfi PP; Grignani F; Alcalay M; Mencarelli A; Biondi A; LoCoco F; Grignani F; Pelicci PG
Oncogene; 1991 Jul; 6(7):1285-92. PubMed ID: 1650447
[TBL] [Abstract][Full Text] [Related]
18. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
19. Differentiation therapy in acute promyelocytic leukemia: European experience.
Degos L
J Cell Physiol; 1997 Nov; 173(2):285-7. PubMed ID: 9365538
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]